CompuGroup Medical SE & Co. KGaA
CMPUY · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $286 | $309 | $283 | $277 |
| % Growth | -7.3% | 8.9% | 2.2% | – |
| Cost of Goods Sold | $44 | $54 | $45 | $210 |
| Gross Profit | $242 | $254 | $238 | $67 |
| % Margin | 84.5% | 82.4% | 84% | 24.1% |
| R&D Expenses | $0 | $0 | $0 | $6 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $219 | $220 | $238 | $34 |
| Operating Expenses | $219 | $220 | $238 | $40 |
| Operating Income | $22 | $35 | $0 | $27 |
| % Margin | 7.8% | 11.2% | 0% | 9.6% |
| Other Income/Exp. Net | -$7 | -$31 | $12 | -$7 |
| Pre-Tax Income | $16 | $4 | $12 | $20 |
| Tax Expense | $5 | $10 | $4 | $6 |
| Net Income | $11 | -$6 | $9 | $14 |
| % Margin | 3.8% | -2.1% | 3% | 5% |
| EPS | 0.21 | -0.13 | 0.17 | 0.34 |
| % Growth | 261.5% | -176.5% | -50% | – |
| EPS Diluted | 0.21 | -0.13 | 0.17 | 0.34 |
| Weighted Avg Shares Out | 52 | 52 | 52 | 52 |
| Weighted Avg Shares Out Dil | 52 | 52 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $0 | $0 |
| Interest Expense | $9 | $3 | $14 | $8 |
| Depreciation & Amortization | $27 | $29 | $27 | $28 |
| EBITDA | $52 | $36 | $54 | $56 |
| % Margin | 18% | 11.6% | 19.1% | 20.2% |